CLINICAL TRIALS PROFILE FOR ALCAINE

All Clinical Trials for ALCAINE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT02951351 ↗	Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections	Completed	Research to Prevent Blindness	N/A	2016-10-12	The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
NCT02951351 ↗	Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections	Completed	VitreoRetinal Surgery, PA	N/A	2016-10-12	The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
NCT02951351 ↗	Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections	Completed	Mayo Clinic	N/A	2016-10-12	The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
NCT02973581 ↗	SPI-directed Analgesia for Vitreoretinal Surgeries	Completed	Silesian University of Medicine	N/A	2016-02-01	The aim of this randomized trial is to assess the efficacy of SPI-directed analgesia for vitreoretinal surgeries (VRS), presence of PONV and oculocardiac reflex (OCR) and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively. Patients received general anaesthesia alone or combined with either preemptive analgesia using topical solution of 0,5% proxymetacaine or peribulbar block (0,5% bupivacaine with 2% lidokaine) or preemptive intravenous infusion of 1,0 g of metamizol or preemptive intravenous infusion of acetaminophen in a doseof 10-15mg/kg of body weight.
NCT02973581 ↗	SPI-directed Analgesia for Vitreoretinal Surgeries	Completed	Medical University of Silesia	N/A	2016-02-01	The aim of this randomized trial is to assess the efficacy of SPI-directed analgesia for vitreoretinal surgeries (VRS), presence of PONV and oculocardiac reflex (OCR) and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively. Patients received general anaesthesia alone or combined with either preemptive analgesia using topical solution of 0,5% proxymetacaine or peribulbar block (0,5% bupivacaine with 2% lidokaine) or preemptive intravenous infusion of 1,0 g of metamizol or preemptive intravenous infusion of acetaminophen in a doseof 10-15mg/kg of body weight.

Clinical Trial Conditions for ALCAINE

Condition Name

Condition Name for ALCAINE
Intervention	Trials
Dacryocystitis	2
Dacryostenosis	2
Epiphora	2
Injection Site	1

Condition MeSH

Condition MeSH for ALCAINE
Intervention	Trials
Lacrimal Apparatus Diseases	2
Dacryocystitis	2
Myopia	1
Macular Edema	1

Clinical Trial Locations for ALCAINE

Trials by Country

Trials by Country for ALCAINE
Location	Trials
United States	3
China	1
Poland	1
Taiwan	1

Trials by US State

Trials by US State for ALCAINE
Location	Trials
Louisiana	1
Michigan	1
Minnesota	1

Clinical Trial Progress for ALCAINE

Clinical Trial Phase

Clinical Trial Phase for ALCAINE
Clinical Trial Phase	Trials
Phase 4	3
N/A	2
Early Phase 1	1

Clinical Trial Status

Clinical Trial Status for ALCAINE
Clinical Trial Phase	Trials
Recruiting	3
Completed	2
Unknown status	1

Clinical Trial Sponsors for ALCAINE

Sponsor Name

Sponsor Name for ALCAINE
Sponsor	Trials
Louisiana State University Health Sciences Center in New Orleans	1
Buddhist Tzu Chi General Hospital	1
Research to Prevent Blindness	1

Sponsor Type

Sponsor Type for ALCAINE
Sponsor	Trials
Other	10